GrippeBelgiqueV4, Main, Exploration, bibRecord, 000058

Online monitoring of flu in Belgium.

Identifieur interne : 000058 ( Main/Exploration ); précédent : 000057; suivant : 000059

Online monitoring of flu in Belgium.

Auteurs : Dirk Devroey [Belgique] ; Pascal Semaille ; Johan Vansintejan ; Jan Vandevoorde ; Erwin Van De Vijver

Source :

Influenza and other respiratory viruses [ 1750-2659 ] ; 2011.

RBID : pubmed:21668686

Descripteurs français

KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Antiviraux (usage thérapeutique), Belgique (épidémiologie), Enfant, Enfant d'âge préscolaire, Grippe humaine (mortalité), Grippe humaine (traitement médicamenteux), Grippe humaine (virologie), Grippe humaine (épidémiologie), Hospitalisation, Humains, Jeune adulte, Mâle, Notification des maladies à déclaration obligatoire (), Oséltamivir (usage thérapeutique), Pandémies, Sous-type H1N1 du virus de la grippe A (physiologie), Sujet âgé, Surveillance de la population (), Systèmes en direct, Zanamivir (usage thérapeutique).
MESH :
- mortalité : Grippe humaine.
- physiologie : Sous-type H1N1 du virus de la grippe A.
- traitement médicamenteux : Grippe humaine.
- usage thérapeutique : Antiviraux, Oséltamivir, Zanamivir.
- virologie : Grippe humaine.
- épidémiologie : Belgique, Grippe humaine.
- Adolescent, Adulte, Adulte d'âge moyen, Enfant, Enfant d'âge préscolaire, Hospitalisation, Humains, Jeune adulte, Mâle, Notification des maladies à déclaration obligatoire, Pandémies, Sujet âgé, Surveillance de la population, Systèmes en direct.
Wicri :
- geographic : Belgique.

English descriptors

KwdEn :
- Adolescent, Adult, Aged, Antiviral Agents (therapeutic use), Belgium (epidemiology), Child, Child, Preschool, Disease Notification (methods), Hospitalization, Humans, Influenza A Virus, H1N1 Subtype (physiology), Influenza, Human (drug therapy), Influenza, Human (epidemiology), Influenza, Human (mortality), Influenza, Human (virology), Male, Middle Aged, Online Systems, Oseltamivir (therapeutic use), Pandemics, Population Surveillance (methods), Young Adult, Zanamivir (therapeutic use).
MESH :
- chemical , therapeutic use : Antiviral Agents, Oseltamivir, Zanamivir.
- geographic , epidemiology : Belgium.
- drug therapy : Influenza, Human.
- epidemiology : Influenza, Human.
- methods : Disease Notification, Population Surveillance.
- mortality : Influenza, Human.
- physiology : Influenza A Virus, H1N1 Subtype.
- virology : Influenza, Human.
- Adolescent, Adult, Aged, Child, Child, Preschool, Hospitalization, Humans, Male, Middle Aged, Online Systems, Pandemics, Young Adult.

Abstract

BACKGROUND

The diagnosis and treatment of patients with the A(H1N1) pandemic flu caused some serious burden for general practitioners (GPs) in the summer and autumn of 2009.

OBJECTIVE

The aim of this study was to track the incidence of influenza and influenza-like illness (ILI) in Belgium and to describe the characteristics of the affected patients.

METHODS

In July 2009, the Belgian online influenza surveillance system (BOISS) was set up to monitor the spread of influenza and ILI. Registrations were made by 93 GPs from all 10 Belgian provinces who participated at least 1 week during the first 12 months of the registration. Only patients who met the WHO criteria for flu were recorded.

RESULTS

In total, 1254 patients (53% men) with influenza or ILI were included. Mainly younger persons were affected: 43% was under the age of 20 years. A risk factor for influenza-related complications was determined in 19% of cases, mainly patients with chronic respiratory problems. A treatment with oseltamivir or zanamivir was prescribed in 13%, and 3% of the patients was admitted to a hospital. The time of the peak incidence (44th week) and the magnitude (623 cases per week per 100,000 inhabitants) corresponded with the figures of the existing paper-based registration network. The small sample size and possible reporting biases may have influenced the findings of the study.

CONCLUSIONS

The BOISS provides a good alternative to conduct surveillance activities for influenza and ILI in Belgium. It provides complementary information regarding ILI compared to the existing data capturing.

DOI: 10.1111/j.1750-2659.2011.00239.x
PubMed: 21668686

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000066
to stream Main, to step Curation: 000066

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Online monitoring of flu in Belgium.</title>
<author><name sortKey="Devroey, Dirk" sort="Devroey, Dirk" uniqKey="Devroey D" first="Dirk" last="Devroey">Dirk Devroey</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Family Practice, Vrije Universiteit Brussel, Brussels, Belgium. dirk.devroey@vub.ac.be</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Family Practice, Vrije Universiteit Brussel, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Semaille, Pascal" sort="Semaille, Pascal" uniqKey="Semaille P" first="Pascal" last="Semaille">Pascal Semaille</name>
</author>
<author><name sortKey="Vansintejan, Johan" sort="Vansintejan, Johan" uniqKey="Vansintejan J" first="Johan" last="Vansintejan">Johan Vansintejan</name>
</author>
<author><name sortKey="Vandevoorde, Jan" sort="Vandevoorde, Jan" uniqKey="Vandevoorde J" first="Jan" last="Vandevoorde">Jan Vandevoorde</name>
</author>
<author><name sortKey="Van De Vijver, Erwin" sort="Van De Vijver, Erwin" uniqKey="Van De Vijver E" first="Erwin" last="Van De Vijver">Erwin Van De Vijver</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21668686</idno>
<idno type="pmid">21668686</idno>
<idno type="doi">10.1111/j.1750-2659.2011.00239.x</idno>
<idno type="wicri:Area/Main/Corpus">000066</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000066</idno>
<idno type="wicri:Area/Main/Curation">000066</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000066</idno>
<idno type="wicri:Area/Main/Exploration">000066</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Online monitoring of flu in Belgium.</title>
<author><name sortKey="Devroey, Dirk" sort="Devroey, Dirk" uniqKey="Devroey D" first="Dirk" last="Devroey">Dirk Devroey</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Family Practice, Vrije Universiteit Brussel, Brussels, Belgium. dirk.devroey@vub.ac.be</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Family Practice, Vrije Universiteit Brussel, Brussels</wicri:regionArea>
<placeName><settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Semaille, Pascal" sort="Semaille, Pascal" uniqKey="Semaille P" first="Pascal" last="Semaille">Pascal Semaille</name>
</author>
<author><name sortKey="Vansintejan, Johan" sort="Vansintejan, Johan" uniqKey="Vansintejan J" first="Johan" last="Vansintejan">Johan Vansintejan</name>
</author>
<author><name sortKey="Vandevoorde, Jan" sort="Vandevoorde, Jan" uniqKey="Vandevoorde J" first="Jan" last="Vandevoorde">Jan Vandevoorde</name>
</author>
<author><name sortKey="Van De Vijver, Erwin" sort="Van De Vijver, Erwin" uniqKey="Van De Vijver E" first="Erwin" last="Van De Vijver">Erwin Van De Vijver</name>
</author>
</analytic>
<series><title level="j">Influenza and other respiratory viruses</title>
<idno type="eISSN">1750-2659</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Belgium (epidemiology)</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Disease Notification (methods)</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Influenza A Virus, H1N1 Subtype (physiology)</term>
<term>Influenza, Human (drug therapy)</term>
<term>Influenza, Human (epidemiology)</term>
<term>Influenza, Human (mortality)</term>
<term>Influenza, Human (virology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Online Systems</term>
<term>Oseltamivir (therapeutic use)</term>
<term>Pandemics</term>
<term>Population Surveillance (methods)</term>
<term>Young Adult</term>
<term>Zanamivir (therapeutic use)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Antiviraux (usage thérapeutique)</term>
<term>Belgique (épidémiologie)</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Grippe humaine (mortalité)</term>
<term>Grippe humaine (traitement médicamenteux)</term>
<term>Grippe humaine (virologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Notification des maladies à déclaration obligatoire ()</term>
<term>Oséltamivir (usage thérapeutique)</term>
<term>Pandémies</term>
<term>Sous-type H1N1 du virus de la grippe A (physiologie)</term>
<term>Sujet âgé</term>
<term>Surveillance de la population ()</term>
<term>Systèmes en direct</term>
<term>Zanamivir (usage thérapeutique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiviral Agents</term>
<term>Oseltamivir</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Belgium</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Disease Notification</term>
<term>Population Surveillance</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Sous-type H1N1 du virus de la grippe A</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Influenza A Virus, H1N1 Subtype</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antiviraux</term>
<term>Oséltamivir</term>
<term>Zanamivir</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Influenza, Human</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Belgique</term>
<term>Grippe humaine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Hospitalization</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Online Systems</term>
<term>Pandemics</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Enfant</term>
<term>Enfant d'âge préscolaire</term>
<term>Hospitalisation</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Notification des maladies à déclaration obligatoire</term>
<term>Pandémies</term>
<term>Sujet âgé</term>
<term>Surveillance de la population</term>
<term>Systèmes en direct</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Belgique</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b>
</p>
<p>The diagnosis and treatment of patients with the A(H1N1) pandemic flu caused some serious burden for general practitioners (GPs) in the summer and autumn of 2009.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b>
</p>
<p>The aim of this study was to track the incidence of influenza and influenza-like illness (ILI) in Belgium and to describe the characteristics of the affected patients.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>In July 2009, the Belgian online influenza surveillance system (BOISS) was set up to monitor the spread of influenza and ILI. Registrations were made by 93 GPs from all 10 Belgian provinces who participated at least 1 week during the first 12 months of the registration. Only patients who met the WHO criteria for flu were recorded.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>In total, 1254 patients (53% men) with influenza or ILI were included. Mainly younger persons were affected: 43% was under the age of 20 years. A risk factor for influenza-related complications was determined in 19% of cases, mainly patients with chronic respiratory problems. A treatment with oseltamivir or zanamivir was prescribed in 13%, and 3% of the patients was admitted to a hospital. The time of the peak incidence (44th week) and the magnitude (623 cases per week per 100,000 inhabitants) corresponded with the figures of the existing paper-based registration network. The small sample size and possible reporting biases may have influenced the findings of the study.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>The BOISS provides a good alternative to conduct surveillance activities for influenza and ILI in Belgium. It provides complementary information regarding ILI compared to the existing data capturing.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21668686</PMID>
<DateCompleted><Year>2011</Year>
<Month>11</Month>
<Day>23</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1750-2659</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>5</Volume>
<Issue>5</Issue>
<PubDate><Year>2011</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>Influenza and other respiratory viruses</Title>
<ISOAbbreviation>Influenza Other Respir Viruses</ISOAbbreviation>
</Journal>
<ArticleTitle>Online monitoring of flu in Belgium.</ArticleTitle>
<Pagination><MedlinePgn>351-6</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1750-2659.2011.00239.x</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The diagnosis and treatment of patients with the A(H1N1) pandemic flu caused some serious burden for general practitioners (GPs) in the summer and autumn of 2009.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The aim of this study was to track the incidence of influenza and influenza-like illness (ILI) in Belgium and to describe the characteristics of the affected patients.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">In July 2009, the Belgian online influenza surveillance system (BOISS) was set up to monitor the spread of influenza and ILI. Registrations were made by 93 GPs from all 10 Belgian provinces who participated at least 1 week during the first 12 months of the registration. Only patients who met the WHO criteria for flu were recorded.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 1254 patients (53% men) with influenza or ILI were included. Mainly younger persons were affected: 43% was under the age of 20 years. A risk factor for influenza-related complications was determined in 19% of cases, mainly patients with chronic respiratory problems. A treatment with oseltamivir or zanamivir was prescribed in 13%, and 3% of the patients was admitted to a hospital. The time of the peak incidence (44th week) and the magnitude (623 cases per week per 100,000 inhabitants) corresponded with the figures of the existing paper-based registration network. The small sample size and possible reporting biases may have influenced the findings of the study.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The BOISS provides a good alternative to conduct surveillance activities for influenza and ILI in Belgium. It provides complementary information regarding ILI compared to the existing data capturing.</AbstractText>
<CopyrightInformation>© 2011 Blackwell Publishing Ltd.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Devroey</LastName>
<ForeName>Dirk</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Family Practice, Vrije Universiteit Brussel, Brussels, Belgium. dirk.devroey@vub.ac.be</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Semaille</LastName>
<ForeName>Pascal</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Vansintejan</LastName>
<ForeName>Johan</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Vandevoorde</LastName>
<ForeName>Jan</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y"><LastName>Van De Vijver</LastName>
<ForeName>Erwin</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2011</Year>
<Month>03</Month>
<Day>07</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Influenza Other Respir Viruses</MedlineTA>
<NlmUniqueID>101304007</NlmUniqueID>
<ISSNLinking>1750-2640</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>L6O3XI777I</RegistryNumber>
<NameOfSubstance UI="D053243">Zanamivir</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001530" MajorTopicYN="N" Type="Geographic">Belgium</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018563" MajorTopicYN="N">Disease Notification</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053118" MajorTopicYN="N">Influenza A Virus, H1N1 Subtype</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009862" MajorTopicYN="N">Online Systems</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053243" MajorTopicYN="N">Zanamivir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>6</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>12</Month>
<Day>13</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">21668686</ArticleId>
<ArticleId IdType="doi">10.1111/j.1750-2659.2011.00239.x</ArticleId>
<ArticleId IdType="pmc">PMC4942047</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Aust Fam Physician. 2009 Nov;38(11):932-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19893847</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Technol Assess. 2009 Nov;13(58):1-265, iii-iv</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19954682</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Salud Publica Mex. 2009 Sep-Oct;51(5):361-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19936549</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Ter. 2009;160(3):243-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19756328</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Br J Community Nurs. 2009 Sep;14(9):405-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19749660</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2009 Nov 05;14(44):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19941777</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Saudi Med J. 2009 Dec;30(12):1532-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19936415</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>CMAJ. 2010 Feb 9;182(2):131-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19959592</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2009 Nov 05;14(44):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19941773</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2009 Nov 05;14(44):null</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19941779</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Med. 2009 Dec;6(12):e1000207</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19997612</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Crit Care Med. 2010 Apr;38(4 Suppl):e91-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19935413</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Rural Remote Health. 2009 Apr-Jun;9(2):1251</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19534568</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Med J Aust. 2009 Aug 3;191(3):151-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19645644</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Belgique</li>
</country>
<region><li>Région de Bruxelles-Capitale</li>
</region>
<settlement><li>Bruxelles</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Semaille, Pascal" sort="Semaille, Pascal" uniqKey="Semaille P" first="Pascal" last="Semaille">Pascal Semaille</name>
<name sortKey="Van De Vijver, Erwin" sort="Van De Vijver, Erwin" uniqKey="Van De Vijver E" first="Erwin" last="Van De Vijver">Erwin Van De Vijver</name>
<name sortKey="Vandevoorde, Jan" sort="Vandevoorde, Jan" uniqKey="Vandevoorde J" first="Jan" last="Vandevoorde">Jan Vandevoorde</name>
<name sortKey="Vansintejan, Johan" sort="Vansintejan, Johan" uniqKey="Vansintejan J" first="Johan" last="Vansintejan">Johan Vansintejan</name>
</noCountry>
<country name="Belgique"><region name="Région de Bruxelles-Capitale"><name sortKey="Devroey, Dirk" sort="Devroey, Dirk" uniqKey="Devroey D" first="Dirk" last="Devroey">Dirk Devroey</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeBelgiqueV4/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000058 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000058 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    GrippeBelgiqueV4
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21668686
   |texte=   Online monitoring of flu in Belgium.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21668686" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeBelgiqueV4

This area was generated with Dilib version V0.6.35.
Data generation: Mon Jul 6 21:52:38 2020. Site generation: Sat Sep 26 09:27:55 2020

	Corpus GrippeBelgiqueV4
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Corpus GrippeBelgiqueV4

Online monitoring of flu in Belgium.

Online monitoring of flu in Belgium.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki